Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Immunocore Holdings PLC - ADR - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
IMCR
Nasdaq
8731
http://www.immunocore.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Immunocore Holdings PLC - ADR
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
- Mar 13th, 2024 3:07 pm
Immunocore presented two posters at CROI 2024
- Mar 5th, 2024 9:30 pm
Immunocore to present at upcoming investor conferences
- Mar 1st, 2024 12:00 pm
Immunocore Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
- Mar 1st, 2024 10:34 am
Immunocore Holdings plc (NASDAQ:IMCR) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 3:51 pm
Immunocore Holdings PLC (IMCR) Reports Strong Revenue Growth Amidst Expansion and Clinical ...
- Feb 28th, 2024 9:53 pm
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
- Feb 28th, 2024 12:34 pm
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial
- Feb 22nd, 2024 12:00 pm
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024
- Feb 21st, 2024 12:00 pm
Sarepta's (SRPT) DMD Drug sBLA Gets FDA's Priority Tag, Stock Up
- Feb 19th, 2024 11:28 am
Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology
- Feb 14th, 2024 11:00 am
Zoetis' (ZTS) Q4 Earnings Miss Expectations, Sales Beat
- Feb 13th, 2024 4:22 pm
5 Biotech Stocks to Consider for Your Portfolio in 2024
- Feb 13th, 2024 2:00 pm
Immunovant (IMVT) Up 3% as Q3 Earnings Top, Pipeline in Focus
- Feb 13th, 2024 12:26 pm
Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma
- Feb 12th, 2024 2:13 pm
REGENXBIO's (RGNX) Hunter Syndrome Study Meets Goal, Stock Up
- Feb 8th, 2024 2:36 pm
Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up
- Feb 7th, 2024 1:34 pm
Deciphera (DCPH) Q4 Loss Narrower Than Expected, Revenues Beat
- Feb 7th, 2024 1:28 pm
Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?
- Feb 1st, 2024 10:16 am
Immunocore Prices Upsized Convertible Senior Notes Offering
- Jan 31st, 2024 4:30 am
Scroll